Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 27 Dec 2024 for HLS Therapeutics Inc., €1,308.
Filing timeline
BuySaleNorma Beauchamp
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
No signal scores available.
Norma Beauchamp: trading record in brief
This profile gathers the share dealings of Norma Beauchamp in HLS Therapeutics Inc. We count 3 filings; the first trade dates from 18 June 2021 and the latest from 24 December 2024.
Market trades split into 1 purchase (€1,308) and 1 sale (€1,120). On balance, insiders were net buyers of €189. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2024 to date brings 1 purchase and 1 sale.
Most recently, on 27 December 2024, the filings show an open-market purchase worth €1,308 in HLS Therapeutics Inc. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Norma Beauchamp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
500 shares@ CA$3.91453.9% of flowCommon SharesTSXSEDI:4424631
Canonical exit: 24 Mar 2025 (T+90)
500 shares@ CA$3.31Common SharesTSXSEDI:4401694
Common SharesTSXSEDI:3766379
3 of 3 declarations
